Group One Trading
RCKT icon

Group One Trading’s Rocket Pharmaceuticals RCKT Stock Holding History

Group One Trading’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.1K Buy
8,400
+6,800
+425% +$27K ﹤0.01% 5668
2025
Q4 		$5.62K Sell
1,600
-6,000
-79% -$20.5K ﹤0.01% 7130
2025
Q3 		$24.8K Buy
7,600
+4,200
+124% +$13.2K ﹤0.01% 6534
2025
Q2 		$8.33K Sell
3,400
-18,700
-85% -$94.7K ﹤0.01% 6828
2025
Q1 		$147K Buy
22,100
+14,100
+176% +$139K ﹤0.01% 4266
2024
Q4 		$101K Buy
8,000
+5,900
+281% +$88.8K ﹤0.01% 4516
2024
Q3 		$38.8K Sell
2,100
-16,400
-89% -$336K ﹤0.01% 4815
2024
Q2 		$398K Buy
18,500
+11,700
+172% +$269K ﹤0.01% 2771
2024
Q1 		$183K Sell
6,800
-20,900
-75% -$594K ﹤0.01% 3632
2023
Q4 		$830K Buy
27,700
+26,600
+2,418% +$587K ﹤0.01% 2635
2023
Q3 		$22.5K Buy
1,100
+600
+120% +$10.9K ﹤0.01% 5799
2023
Q2 		$9.94K Buy
500
+300
+150% +$6.06K ﹤0.01% 6398
2023
Q1 		$3.43K Buy
200
+100
+100% +$1.96K ﹤0.01% 6443
2022
Q4 		$1.96K Buy
+100
New +$1.84K ﹤0.01% 6662
2022
Q1 		– Sell
-100
Closed -$2K – 8569
2021
Q4 		$2K Buy
+100
New +$2.73K ﹤0.01% 7899
2021
Q3 		– Sell
-10,800
Closed -$478K – 8681
2021
Q2 		$478K Sell
10,800
-9,400
-47% -$408K ﹤0.01% 4265
2021
Q1 		$896K Buy
20,200
+9,000
+80% +$494K ﹤0.01% 3364
2020
Q4 		$614K Buy
11,200
+6,900
+160% +$252K ﹤0.01% 3092
2020
Q3 		$98K Buy
+4,300
New +$106K ﹤0.01% 4207
2020
Q1 		– Sell
-6,000
Closed -$137K – 5661
2019
Q4 		$137K Buy
+6,000
New +$100K ﹤0.01% 3441
2018
Q1 		– Sell
-2,250
Closed -$23K – 5229
2017
Q4 		$23K Buy
+2,250
New +$22.3K ﹤0.01% 4102
2017
Q3 		– Sell
-3,750
Closed -$29K – 5094
2017
Q2 		$29K Sell
3,750
-250
-6% -$1.86K ﹤0.01% 3799
2017
Q1 		$32K Sell
4,000
-1,700
-30% -$11.4K ﹤0.01% 3655
2016
Q4 		$139K Buy
5,700
+5,675
+22,700% +$162K ﹤0.01% 2651
2016
Q3 		$1K Hold
25
– – ﹤0.01% 4448
2016
Q2 		$1K Hold
25
– – ﹤0.01% 4517
2016
Q1 		$1K Buy
+25
New +$750 ﹤0.01% 4448

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Group One Trading's RCKT Position: Q1 2026 in Review

Group One Trading increased its Rocket Pharmaceuticals (RCKT) stake by 523% in Q1 2026, buying an estimated $191K and bringing the position to 57,382 shares worth $205K. The position accounts for ﹤0.01% of the portfolio, ranked #4087.

Group One Trading first reported a position in RCKT in Q3 2016 and has held it in 19 quarters since. 198 funds tracked by Wall St. Rank hold RCKT as of Q1 2026.

  • Group One Trading held 57,382 shares of Rocket Pharmaceuticals worth $205K as of Q1 2026.
  • Group One Trading bought 48,178 Rocket Pharmaceuticals shares in Q1 2026, an estimated $191K.
  • Rocket Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4087 holding.
  • Group One Trading first reported a position in Rocket Pharmaceuticals in Q3 2016 and has held it in 19 quarters since.
  • 198 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.